Creso Pharma Limited filed its Annual on Mar 31, 2023 for the period ending Dec 31, 2022. In this report its auditor, , gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.003 AUD | +20.00% | +50.00% | -92.50% |
09/05 | Melodiol Global's Mernova Unit Launches More Products; Shares Jump 50% | MT |
16/04 | Melodiol Global's Revenue Surges 79% in Q1 | MT |
1st Jan change | Capi. | |
---|---|---|
-92.50% | 1.11M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- ME1 Stock
- News Melodiol Global Health Limited
- Creso Pharma Limited Auditor Raises 'Going Concern' Doubt